Land: New Zealand
Sprog: engelsk
Kilde: Medsafe (Medicines Safety Authority)
Influenza virus A/Wellington/I/2004(H3N2)-like strain 10ug ([Influenza virus A/Wellington/I/2004 IVR-139(10 µg/HA)]); ; Influenza virus B/Shanghai/361/2002-like strain 15ug ([B/Jiangsu/10/2003 (15µg/HA)]); ; Influenza virus haemagglutinin type A/New Caledonia/20/99 H1N1-like strain 15ug ([A/New Caledonia/20/99 IVR-116 (15µg/HA)]);
sanofi-aventis new zealand limited
Influenza virus A/Wellington/I/2004(H3N2)-like strain 10 µg ([Influenza virus A/Wellington/I/2004 IVR-139(10 µg/HA)])
10µg/15µg/15µg per dose
Solution for injection
Active: Influenza virus A/Wellington/I/2004(H3N2)-like strain 10ug ([Influenza virus A/Wellington/I/2004 IVR-139(10 µg/HA)]) Influenza virus B/Shanghai/361/2002-like strain 15ug ([B/Jiangsu/10/2003 (15µg/HA)]) Influenza virus haemagglutinin type A/New Caledonia/20/99 H1N1-like strain 15ug ([A/New Caledonia/20/99 IVR-116 (15µg/HA)]) Excipient: Dibasic sodium phosphate dihydrate Monobasic potassium phosphate Neomycin Sodium chloride Water for injection
Syringe, glass, single dose,
Prescription
Prescription
Sanofi Pasteur SA
Package - Contents - Shelf Life: Syringe, glass, single dose - 1 dose units - 12 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) - Syringe, glass, 10 x pre-filled syringe - 10 dose units - 12 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze)
2005-04-01
VAXIGRIP ® 1 VAXIGRIP ® _Inactivated Influenza Vaccine (split virion) _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU OR YOUR CHILD IS VACCINATED. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This vaccine has been prescribed for you or your child. Do not pass it on to others. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET: What VAXIGRIP is and what they are used for Before you or your child is given VAXIGRIP How VAXIGRIP is given Possible side effects Storing VAXIGRIP Further Information WHAT VAXIGRIP IS AND WHAT THEY ARE USED FOR VAXIGRIP is a vaccine. These vaccines help to protect you or your child against influenza (flu), particularly if you or your child runs a high risk of associated complications. VAXIGRIP should be used according to official recommendations. When a person is given VAXIGRIP, the immune system (the body’s natural defence system) will produce its own protection (antibodies) against the disease. None of the ingredients in the vaccine can cause flu. Flu is a disease that can spread rapidly and is caused by different types of virus strains that can change every year. This is why you or your child may need to be vaccinated every year. The greatest risk of catching flu is during the cold months. If you or your child was not vaccinated in the autumn, it is still possible to do it until spring since you or your child runs the risk of catching flu until then. Your doctor will be able to recommend the best time to be vaccinated. VAXIGRIP will protect you or your child against the three strains of virus contained in the vaccine after about 2 to 3 weeks following the injection. The incubation period for flu is a few days, so if you or your child is exposed to flu immediately before or after your vaccination, you or your child c Læs hele dokumentet
2017 Season vax-vax-jr-ccdsv8-dsv3-2-22nov16 Page 1 of 13 NEW ZEALAND DATA SHEET NAME OF THE MEDICINE VAXIGRIP ® INACTIVATED INFLUENZA VACCINE (SPLIT VIRION) DESCRIPTION VAXIGRIP is a sterile suspension of influenza virus for intramuscular or deep subcutaneous injection. It is a purified, inactivated, split virion vaccine. VAXIGRIP contains the following strains of influenza virus: A/Michigan/45/2015 NYMC X-275 (A/Michigan/45/2015 [H1N1]pdm09- like), A/Hong Kong/4801/2014 NYMC X-263B (A/Hong Kong/4801/2014 [H3N2]- like) and B/Brisbane/60/2008 wild type (B/Brisbane/60/2008-like) Each 0.5 mL pre-filled syringe contains 15 µg haemagglutinin of each of the 3 strains in a buffered saline solution. A buffered saline solution contains the following excipients – sodium chloride, potassium chloride, sodium phosphate – dibasic dihydrate, potassium phosphate – monobasic and water for injection. The vaccine is prepared from virus grown in the allantoic cavity of embryonated eggs, concentrated, purified by zonal centrifugation in a sucrose gradient, split by octoxinol 9 (Triton X-100), inactivated by formaldehyde and then diluted in phosphate buffered saline solution to the required concentration. No adjuvant or preservative is added. The vaccine may contain traces of formaldehyde (≤ 30 µg), octoxinol 9 (≤ 200 µg) and neomycin (≤ 20 picogram). VAXIGRIP does not contain more than 0.05 µg ovalbumin per dose. The type and amount of viral antigens contained in VAXIGRIP conform to the annual requirements of the Australian Influenza Vaccine Committee (AIVC) and the World Health Organization (WHO) recommendations for the season. PHARMACOLOGY Influenza vaccines have been shown to give antibody responses and to provide protection against clinical illness in a proportion of vaccinees. Because the influenza virus is capricious antigenically and because significant changes in its antigenic behaviour may occur from time to time, protection afforded by VAXIGRIP is limited to the strains from which the vaccine h Læs hele dokumentet